<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANP</journal-id>
<journal-id journal-id-type="hwp">spanp</journal-id>
<journal-title>Australian &amp; New Zealand Journal of Psychiatry</journal-title>
<issn pub-type="ppub">0004-8674</issn>
<issn pub-type="epub">1440-1614</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0004867412457998</article-id>
<article-id pub-id-type="publisher-id">10.1177_0004867412457998</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correspondence</subject>
<subj-group subj-group-type="heading">
<subject>Commentaries</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transparency and accountability in early psychosis intervention research</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Raven</surname><given-names>Melissa</given-names></name>
<xref ref-type="aff" rid="aff1-0004867412457998">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jureidini</surname><given-names>Jon</given-names></name>
<xref ref-type="aff" rid="aff2-0004867412457998">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Stuart</surname><given-names>Geoffrey W</given-names></name>
<xref ref-type="aff" rid="aff3-0004867412457998">3</xref>
<xref ref-type="aff" rid="aff4-0004867412457998">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0004867412457998"><label>1</label>Discipline of Public Health, Flinders University, Adelaide, Australia</aff>
<aff id="aff2-0004867412457998"><label>2</label>Discipline of Psychiatry and Discipline of Paediatrics, University of Adelaide, Adelaide, Australia</aff>
<aff id="aff3-0004867412457998"><label>3</label>School of Psychological Science, La Trobe University, Melbourne, Australia</aff>
<aff id="aff4-0004867412457998"><label>4</label>Department of Psychology, University of Melbourne, Melbourne, Australia</aff>
<author-notes>
<corresp id="corresp1-0004867412457998">Melissa Raven, PO Box 333, Goodwood, SA 5034, Australia. Email: <email>melissa.raven@flinders.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>47</volume>
<issue>7</issue>
<fpage>680</fpage>
<lpage>681</lpage>
<permissions>
<copyright-statement>© The Royal Australian and New Zealand College of Psychiatrists 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">The Royal Australian and New Zealand College of Psychiatrists</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Patrick McGorry accuses us of seeking to ‘censor’ early psychosis intervention research by exerting public pressure on independent ethics committees. He further labels us as ‘anti-scientific’, accusing us of threatening much-needed legitimate and ethical research (<xref ref-type="bibr" rid="bibr3-0004867412457998">McGorry, 2012</xref>).</p>
<p>We lodged a complaint (<xref ref-type="bibr" rid="bibr9-0004867412457998">Raven et al., 2011</xref>) in August 2011 with Melbourne Health’s Mental Health Research and Ethics Committee (MHREC) about the North America, Europe, Australia Prodrome (NEURAPRO-Q) trial run by McGorry, in which young people with ‘prodromal psychosis’ would have been prescribed quetiapine (<xref ref-type="bibr" rid="bibr1-0004867412457998">Australian New Zealand Clinical Trials Registry, 2011</xref>). We detailed multiple ethical and methodological problems with the trial, citing many peer-reviewed journal articles.</p>
<p>We would welcome a scientific rebuttal by McGorry of the substance of our criticisms, rather than his reliance on appeal to authority and <italic>ad hominem</italic> arguments. Unfortunately, this has not been forthcoming, consistent with a pattern of disparagement and dismissal of evidence that does not support his claims, inaccurate representation of epidemiological evidence (<xref ref-type="bibr" rid="bibr8-0004867412457998">Raven and Jureidini, 2010</xref>), and inaccurate characterisation of his own research evidence (<xref ref-type="bibr" rid="bibr6-0004867412457998">Raven, 2011</xref>, <xref ref-type="bibr" rid="bibr7-0004867412457998">2013</xref>).</p>
<p>Furthermore, McGorry’s reference to <italic>independent</italic> ethics committees is problematic. Since (at least) 2008, the majority of MHREC members with current relevant research experience have been employees of Orygen Youth Health at the time and/or have had links with McGorry that are classified by the National Health and Medical Research Council as ‘high conflict of interest’ (<xref ref-type="bibr" rid="bibr4-0004867412457998">National Health and Medical Research Council, 2011</xref>). Unfortunately, the MHREC has not only refused to respond to the substance of our complaint, but has also denied any conflicts of interest on the part of MHREC members. This reveals a worrying lack of independence, transparency, and accountability in relation to Australia’s leading early psychosis intervention research programme.</p>
<p>Furthermore, one reason for our complaint was McGorry’s contradictory statements about the role of pre-emptive antipsychotics. In May 2011, while the NEURAPRO-Q trial was being assessed by the MHREC, McGorry responded to MP Martin Whitely’s concerns by publicly declaring that it would not be necessary to use antipsychotics for psychosis risk syndrome because ‘<italic>the whole thrust of the early intervention movement of psychosis is to try to minimize the use of medication until it’s really needed</italic>’ (<xref ref-type="bibr" rid="bibr11-0004867412457998">Weber, 2011</xref>). A few weeks later, he stated his intention to proceed with the trial, worryingly referring to quetiapine as a ‘<italic>broad spectrum mental illness drug</italic>’ (<xref ref-type="bibr" rid="bibr2-0004867412457998">Dunlevy, 2011</xref>), echoing the off-label promotion for which its manufacturer AstraZeneca was fined USD520 million (<xref ref-type="bibr" rid="bibr10-0004867412457998">United States Department of Justice, 2010</xref>).</p>
<p>Finally, we are bemused by McGorry’s objection to his critics’ use of mainstream and social media given his own intensive use of the media as a platform for lobbying and for criticizing his critics, assisted by a ‘campaign director’ (<xref ref-type="bibr" rid="bibr5-0004867412457998">O’Neill, 2011</xref>).</p>
<boxed-text id="boxed-text1-0004867412457998">
<p>See Viewpoint by <xref ref-type="bibr" rid="bibr3-0004867412457998">McGorry, 2012</xref>, 46(4): 313–316</p>
</boxed-text>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Declaration of interest</label>
<p>MR and JJ are members of Healthy Skepticism Inc.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0004867412457998">
<citation citation-type="web">
<collab>Australian New Zealand Clinical Trials Registry</collab> (<year>2011</year>) <source>The NEURAPRO-Q (North America, EURope, Australia PROdrome) Study: A multicentre randomised controlled trial (RCT) to evaluate the effect of Quetiapine and Cognitive-Behavioural Case Management on the incidence of first episode psychosis in Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders</source>. <publisher-loc>Sydney</publisher-loc>: <publisher-name>NHMRC Clinical Trials Centre, University of Sydney</publisher-name>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.anzctr.org.au/trial_view.aspx?id=335264">www.anzctr.org.au/trial_view.aspx?id=335264</ext-link> (<access-date>accessed 12 March 2013</access-date>).</citation>
</ref>
<ref id="bibr2-0004867412457998">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Dunlevy</surname><given-names>S</given-names></name>
</person-group> (<year>2011</year>) <article-title>Schism opens over ills of the mind</article-title>. <source>The Australian</source>, <day>16</day> <month>June</month>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.theaustralian.com.au/news/features/schism-opens-over-ills-of-the-mind/story-e6frg6z6-1226075910650">www.theaustralian.com.au/news/features/schism-opens-over-ills-of-the-mind/story-e6frg6z6-1226075910650</ext-link> (<access-date>12 March 2013</access-date>).</citation>
</ref>
<ref id="bibr3-0004867412457998">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McGorry</surname><given-names>PD</given-names></name>
</person-group> (<year>2012</year>) <article-title>Truth and reality in early intervention</article-title>. <source>Australian and New Zealand Journal of Psychiatry</source> <volume>46</volume>: <fpage>313</fpage>–<lpage>316</lpage>.</citation>
</ref>
<ref id="bibr4-0004867412457998">
<citation citation-type="gov">
<collab>National Health and Medical Research Council</collab> (<year>2011</year>) <source>NHMRC project grants: Peer review guidelines for funding commencing in 2012</source>. <publisher-loc>Canberra</publisher-loc>: <publisher-name>National Health and Medical Research Council</publisher-name>, Available at: <ext-link ext-link-type="uri" xlink:href="http://www.nhmrc.gov.au/_files_nhmrc/file/grants/apply/projects/peer_review_guidelines_nhmrc_2011.pdf">www.nhmrc.gov.au/_files_nhmrc/file/grants/apply/projects/peer_review_guidelines_nhmrc_2011.pdf</ext-link> (<access-date>accessed 12 March 2013</access-date>).</citation>
</ref>
<ref id="bibr5-0004867412457998">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>O’Neill</surname><given-names>L</given-names></name>
</person-group> (<year>2011</year>) <article-title>McGorry in campaign mode from day one.</article-title> <source>Irish Echo: Australia’ Irish Newspaper</source>, <day>15</day> <month>March</month>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.irishecho.com.au/2011/03/15/mcgorry-in-campaign-mode-from-day-one/7935">www.irishecho.com.au/2011/03/15/mcgorry-in-campaign-mode-from-day-one/7935</ext-link> (<access-date>accessed 15 March 2011</access-date>).</citation>
</ref>
<ref id="bibr6-0004867412457998">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Raven</surname><given-names>M</given-names></name>
</person-group> (<year>2011</year>) <article-title>The EPPIC study: methodology, results, and misrepresentation</article-title>. <source>Alliance for Better Access</source>. Available at: <ext-link ext-link-type="uri" xlink:href="http://betteraccess.net/index.php/information/whats-this-about/81-information/104">http://betteraccess.net/index.php/information/whats-this-about/81-information/104</ext-link> (<access-date>accessed 26 July 2012</access-date>).</citation>
</ref>
<ref id="bibr7-0004867412457998">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raven</surname><given-names>M</given-names></name>
</person-group> (<year>2013</year>) <article-title>EPPIC mirage: Cost-effectiveness of early psychosis intervention</article-title>. <source>Australian and New Zealand Journal of Psychiatry</source> <volume>47</volume>: <fpage>599</fpage>–<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr8-0004867412457998">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Raven</surname><given-names>M</given-names></name>
<name><surname>Jureidini</surname><given-names>J</given-names></name>
</person-group> (<year>2010</year>) <article-title>Misleading claims in the mental health reform debate</article-title>. <source>ON LINE opinion</source>, <day>9</day> <month>August</month>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.onlineopinion.com.au/view.asp?article=10793">www.onlineopinion.com.au/view.asp?article=10793</ext-link> (<access-date>accessed 12 March 2013</access-date>).</citation>
</ref>
<ref id="bibr9-0004867412457998">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Raven</surname><given-names>M</given-names></name>
<name><surname>Stuart</surname><given-names>G</given-names></name>
<name><surname>Jureidini</surname><given-names>J</given-names></name><etal/>
</person-group>. (<year>2011</year>) <article-title>NEURAPRO-Q Study: Objection to trial on ethical and methodological grounds</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="http://images.smh.com.au/file/2011/08/20/2570828/mcgorryletter.pdf">http://images.smh.com.au/file/2011/08/20/2570828/mcgorryletter.pdf</ext-link> (<access-date>accessed 12 March 2013</access-date>).</citation>
</ref>
<ref id="bibr10-0004867412457998">
<citation citation-type="gov">
<collab>United States Department of Justice</collab> (<year>2010</year>) <source>Pharmaceutical giant AstraZeneca to pay $520 million for off-label drug marketing</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>United States Department of Justice</publisher-name>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.justice.gov/opa/pr/2010/April/10-civ-487.html">www.justice.gov/opa/pr/2010/April/10-civ-487.html</ext-link> (<access-date>accessed 12 March 2013</access-date>).</citation>
</ref>
<ref id="bibr11-0004867412457998">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Weber</surname><given-names>D</given-names></name>
</person-group> (<year>2011</year>) <article-title>Professor McGorry hits back at critics. The World Today. ABC News. Australian Broadcasting Corporation</article-title>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.abc.net.au/worldtoday/content/2011/s3222359.htm">www.abc.net.au/worldtoday/content/2011/s3222359.htm</ext-link> (<access-date>accessed 12 March 2013</access-date>).</citation>
</ref>
</ref-list>
</back>
</article>